S&P/ASX 200 Index (ASX: XJO) shares closed 0.46% lower on Wednesday at 8,630.4 points.
Within the 11 market sectors, consumer discretionary shares rose the most, up 2.9% yesterday.
Materials shares also had a strong day after BHP Group Ltd (ASX: BHP) set a new record and resumed the top spot on the ASX 200.
ASX 200 materials shares rose 2%, and BHP shares finished 2.9% higher at $61.52 after resetting their historical high at $62.30.
The financial sector was the laggard, dropping 4%, largely due to Commonwealth Bank of Australia (ASX: CBA) shares diving 10.4%.
Amid this volatility, brokers have indicated continuing confidence in several ASX 200 shares this week.
Let's take a look at which stocks have attracted reiterated buy ratings.
Image source: Getty Images
Insurance Australia Group Ltd (ASX: IAG)
The IAG share price closed at $7.60, up 1.9% on Wednesday.
Over the past month, this ASX 200 insurance share has risen 4.8%.
UBS renewed its buy rating on IAG shares on Wednesday.
The broker raised its 12-month price target from $8.55 to $8.80.
The target suggests a possible 16% capital gain ahead.
National Australia Bank Ltd (ASX: NAB)
The NAB share price finished at $36.86, down 1.5% yesterday.
Over the past month, this ASX 200 bank share has fallen 18%.
UBS renewed its buy rating on NAB shares with a $48.50 target this week.
This implies 31% potential growth ahead.
CSL Ltd (ASX: CSL)
The CSL share price closed at $98.79, up 0.2% on Wednesday.
This ASX 200 healthcare giant has fallen 28% in a month and 59% over 12 months.
Morgans renewed its buy rating on CSL shares this week.
However, the broker slashed its price target from $241.34 to $147.59.
This still suggests very healthy upside of 49% over the next year.
ANZ Group Holdings Ltd (ASX: ANZ)
The ANZ share price closed the session yesterday at $34.57, down 1.6%.
Over the past month, this ASX 200 bank share has fallen 11%.
Citi renewed its buy rating on ANZ shares on Tuesday.
The broker trimmed its 12-month price target from $40.30 to $40.
The target suggests a possible 16% capital gain ahead.
Pro Medicus Ltd (ASX: PME)
The Pro Medicus share price closed at $125.50, down 0.3% on Wednesday.
This ASX 200 healthcare share has fallen 53% over the past 12 months.
The Pro Medicus share price has been in correction mode after hitting a historical peak of $336 in July 2025.
Canaccord Genuity renewed its buy rating on Pro Medicus shares this week.
The broker lowered its target from $180.82 to $168.62, suggesting a possible 34% upside ahead.
Aristocrat Leisure Ltd (ASX: ALL)
The Aristocrat share price closed the session yesterday at $51.94, up 13.3%.
This ASX 200 consumer discretionary share has tumbled 12.9% over six months.
Citi renewed its buy rating on Aristocrat shares with a 12-month target of $65 on Wednesday.
This implies a potential 25% upside ahead.
Temple & Webster Ltd (ASX: TPW)
The Temple & Webster share price closed at $4.98, down 6.4% on Wednesday.
The ASX 200 retail share has fallen 29% in a month and hit a 3-year low of $4.54 yesterday.
Macquarie renewed its buy rating on Temple & Webster shares with a $13.70 target this week.
This implies a potential 173% upside ahead.
Nick Scali Ltd (ASX: NCK)
The Nick Scali share price closed the session yesterday at $14.08, down 2.5%.
Over the past month, this ASX 200 furniture retailer has lost 11% of its valuation.
Macquarie renewed its buy rating on Nick Scali shares with a $21.60 target this week.
This indicates a potential 54% upside ahead.
Metcash Ltd (ASX: MTS)
The Metcash share price closed at $2.97, down 1% on Wednesday.
Over the past six months, this ASX 200 supermarket share has fallen 23%.
UBS renewed its buy rating on Metcash shares with a $3.50 target this week.
This indicates a potential 18% upside ahead.
